Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 3
Expanded Tick-Borne Disease Working Group Reauthorization
Reauthorizes the Tick-Borne Disease Working Group and expands its coordination from HHS alone to the entire federal government, while adding nine new federal agencies to its membership.
- Population Scope Low Directly affects a narrow set of federal agencies and Working Group members, not the general public.
- Budgetary Magnitude Low No funding is authorized or appropriated; the provision makes only structural and membership changes.
- Legal / Regulatory Depth Medium Shifts the Working Group's coordination mandate from a single department to the entire federal government and formally assigns nine additional agencies, creating new procedural duties across multiple departments without altering substantive law.
- Degree of Discretion Granted Medium Expanding membership to thirteen federal agencies and broadening coordination scope gives participating agencies meaningful new roles, but the provision does not delegate rulemaking or grant open-ended regulatory authority.
- Implementation & Enforcement Burden Low No penalties, compliance requirements, or enforcement mechanisms are created; the change is purely organizational.
- Temporal Commitment High The reauthorized Working Group structure carries no expiration date, persisting indefinitely unless Congress acts to repeal or amend it.
No signal yet
Funding / Appropriations Top 3
Vector-Borne Disease Regional Centers Funding Reauthorization
Reauthorizes funding for regional centers of excellence in vector-borne diseases at $12 million per year for fiscal years 2026 through 2030, up from $10 million annually.
- Population Scope Low Directly benefits a discrete set of regional research centers and associated public health infrastructure, not the general population.
- Budgetary Magnitude Low Authorizes $12 million per year for five years (up to $60 million total), a modest discretionary authorization at the lower end of federal program scales.
- Legal / Regulatory Depth Low Updates a dollar figure and fiscal-year range in an existing authorization, leaving program structure, administration, and eligibility unchanged.
- Degree of Discretion Granted Low Sets a ceiling on appropriations without expanding agency authority or delegating new rulemaking power.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are imposed by this funding reauthorization.
- Temporal Commitment Low Authorization expires at the end of FY2030, self-terminating within five years unless Congress acts to extend it.
No signal yet
Funding / Appropriations Top 3
Health Department Vector-Borne Disease Support Funding Reauthorization
Reauthorizes funding to help state and local health departments address vector-borne diseases at $21 million per year for fiscal years 2026 through 2030, up from $20 million annually.
- Population Scope Low Directly affects state and local health departments receiving grants, not the general public, though communities benefit indirectly.
- Budgetary Magnitude Low Authorizes $21 million per year for five years (up to $105 million total), a modest discretionary authorization representing only a $1 million annual increase over the prior level.
- Legal / Regulatory Depth Low Updates a dollar figure and fiscal-year range in an existing authorization, leaving program structure, eligibility, and administration intact.
- Degree of Discretion Granted Low Sets a funding ceiling without expanding agency authority, rulemaking power, or programmatic discretion beyond what the existing statute already provides.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are created by this reauthorization.
- Temporal Commitment Low Same as above.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill reauthorizes and expands two federal programs aimed at fighting tick-borne diseases like Lyme disease. It updates the Tick-Borne Disease Working Group by adding more federal agencies and broadening its coordination across the whole federal government, not just the Department of Health and Human Services (HHS). It also renews funding for regional disease research centers and state health department support programs at slightly higher levels through 2030.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Sep 24, 2026
|
Sep 24, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 3
Expanded Tick-Borne Disease Working Group Reauthorization
Reauthorizes the Tick-Borne Disease Working Group and expands its coordination from HHS alone to the entire federal government, while adding nine new federal agencies to its membership.
- Population Scope Low Directly affects a narrow set of federal agencies and Working Group members, not the general public.
- Budgetary Magnitude Low No funding is authorized or appropriated; the provision makes only structural and membership changes.
- Legal / Regulatory Depth Medium Shifts the Working Group's coordination mandate from a single department to the entire federal government and formally assigns nine additional agencies, creating new procedural duties across multiple departments without altering substantive law.
- Degree of Discretion Granted Medium Expanding membership to thirteen federal agencies and broadening coordination scope gives participating agencies meaningful new roles, but the provision does not delegate rulemaking or grant open-ended regulatory authority.
- Implementation & Enforcement Burden Low No penalties, compliance requirements, or enforcement mechanisms are created; the change is purely organizational.
- Temporal Commitment High The reauthorized Working Group structure carries no expiration date, persisting indefinitely unless Congress acts to repeal or amend it.
No signal yet
Core Policy Mechanism
Expanded Tick-Borne Disease Working Group Reauthorization
Funding / Appropriations Top 3
Vector-Borne Disease Regional Centers Funding Reauthorization
Reauthorizes funding for regional centers of excellence in vector-borne diseases at $12 million per year for fiscal years 2026 through 2030, up from $10 million annually.
- Population Scope Low Directly benefits a discrete set of regional research centers and associated public health infrastructure, not the general population.
- Budgetary Magnitude Low Authorizes $12 million per year for five years (up to $60 million total), a modest discretionary authorization at the lower end of federal program scales.
- Legal / Regulatory Depth Low Updates a dollar figure and fiscal-year range in an existing authorization, leaving program structure, administration, and eligibility unchanged.
- Degree of Discretion Granted Low Sets a ceiling on appropriations without expanding agency authority or delegating new rulemaking power.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are imposed by this funding reauthorization.
- Temporal Commitment Low Authorization expires at the end of FY2030, self-terminating within five years unless Congress acts to extend it.
No signal yet
Funding / Appropriations
Vector-Borne Disease Regional Centers Funding Reauthorization
Funding / Appropriations Top 3
Health Department Vector-Borne Disease Support Funding Reauthorization
Reauthorizes funding to help state and local health departments address vector-borne diseases at $21 million per year for fiscal years 2026 through 2030, up from $20 million annually.
- Population Scope Low Directly affects state and local health departments receiving grants, not the general public, though communities benefit indirectly.
- Budgetary Magnitude Low Authorizes $21 million per year for five years (up to $105 million total), a modest discretionary authorization representing only a $1 million annual increase over the prior level.
- Legal / Regulatory Depth Low Updates a dollar figure and fiscal-year range in an existing authorization, leaving program structure, eligibility, and administration intact.
- Degree of Discretion Granted Low Sets a funding ceiling without expanding agency authority, rulemaking power, or programmatic discretion beyond what the existing statute already provides.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are created by this reauthorization.
- Temporal Commitment Low Same as above.
No signal yet
Funding / Appropriations
Health Department Vector-Borne Disease Support Funding Reauthorization
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: